Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA’s Oncology Divisions Have Been Providing Live Meeting Minutes For Years. Will Others Follow?

12 Jul 2023

• By Derrick Gingery

Meeting minutes — Providing live meeting minutes may be a difficult policy to implement outside the oncology review divisions. • Source: Shutterstock

Related Content

US FDA’s PDUFA VIII Ideas Could Include Creating Regulatory Science Research Program

10 Jun 2023

Supplemental Filings: FDA Expands In-Person Meeting Eligibility Again; Marks Suggests Sponsors Invite Foreign Regulators To FDA Meetings

03 Jun 2023

US FDA's Oncology Division Wants To Know About Your Pipeline, Not Just Your NDAs

20 Nov 2017

Moderna’s COVID-19 Vaccine To Get Real-Time Data Assessment By US FDA

28 Jul 2020

Candidates For The US FDA’s STAR Program Might As Well Be Breakthrough Therapies, Too

27 Jun 2022

For Cell And Gene Therapies, Expedited Designation And Complex Questions Improve FDA Meeting Chances

03 Jun 2022

US FDA Begins Implementing New User Fee Programs, But What About The Actual Fees?

04 Oct 2022

Related Companies

Janssen R&D LLC

Pfizer Inc.

Additional Topics

United States Research & Development Review Pathway Regulation User Fees BioPharmaceutical

More from R&D

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.